Scott Gottlieb, a former deputy commissioner of the U.S. Food and Drug Administration, is President Donald Trump’s choice to lead the agency, according to an emailed statement from the White House.
Gottlieb, 44, served in several senior positions at the FDA during the George W. Bush administration. He has talked extensively about how to lower the cost of prescription drugs by modernizing the agency’s approval process and speeding cheaper generic competitors to market.
Many global cities want to be named the next tech innovation hub. But who’s really in the running?
It’s a question on which there are myriad perspectives and theories — the latest taking the form of a survey by professional service company KPMG. The company recently released part one of it’s yearly technology industry innovation survey (now in its fifth year) — a survey of over 800 “global technology industry leaders” in which KPMG asks about the changing landscape of tech. Part one the survey explores “the rise of new ecosystems of incubators, accelerators, and venture capital alongside government incentives across the world.”
The conviction that competitive differentiation will require effective digital initiatives has led many life-sciences companies to create a new leadership role, chief digital officer (CDO), to guide their digital initiatives.
To understand how these leaders see the digital future and how they are managing for success, we spoke to CDOs and their equivalents at ten pharma companies. These conversations suggest three imperatives for digital efforts: focus on the team applying the tools, not on the tools themselves; make bold, disruptive bets; and optimize the portfolio of initiatives to achieve company priorities, while taking finite resources into account.
The Illinois Science and Technology Coalition (ISTC) today released new data showing record growth in entrepreneurial activity at the state’s universities as part of its Illinois Innovation Index, which reports on the key metrics of the state’s innovation economy. The report found that during the past five academic years, students and faculty at Illinois universities created 804 startups through technology licensing, entrepreneurship programs, competitions and other university initiatives. A record number of these startups, nearly 500, are also staying in the state.
Wed, April 5, 2017 6:00 PM – 8:30 PM EDT
Institute for Bioscience & Biotechnology Research 9600 Gudelsky DriveRockville, MD, Maryland 20850
From patient engagement to data analytics, the Health IT space is one of the hottest sectors in healthcare today. Join our next SoPE event and learn from developers, investors and entrepreneurs how to best get your innovative idea from inception to consumers while anticipating and avoiding the common pitfalls you are bound to encounter along the way.
Moderator: Jeffrey N. Hausfeld MD, MBA, Founder and Chairman – Society of Physician Entprepreneurs, Chairman of the Board and Chief Medical Officer – BioFactura, Inc.
NextGen Venture Partners, a young, Washington, D.C.-based venture firm that’s quarterbacked by a handful of investors but fueled financially by a network of hundreds of part-time investors who help with its portfolio, has raised $22 million for its debut fund. (This if you don’t count a $1 million pool of capital that it raised from its network in 2015.)
We had a quick chat with Jon Bassett, one of the firm’s five partners, late last week to talk about what NextGen is trying to create. That conversation has been edited for length.
The Next Step: VC Investment Update
Entrepreneurs, investors and others: Join the NVTC Small Business and Entrepreneur Committee for the second part of this practical series on raising investment capital. This expert panel will feature some of the most active VCs investing in Greater Washington region companies. The panelists represent active venture investors who have participated in venture rounds in the last year in Greater Washington and are looking to make more investments. The panel will discuss their recent experiences, their desired investee profiles and offer practical advice on raising venture stage capital.
Moderator:
Norm Snyder, CPA, Partner, Aronson LLC
Speakers:
J.S. Gamble, Co-Founder, Blu Ventures Todd Klein, Managing Director and CIO, SWaN & Legend Ventures Adam VeVerka, Director- Business Development, NewSpring Capital Kristin Gunther, Vice President, Revolution Growth
USDA ARS and the USDA SBIR program formed a partnership to encourage USDA SBIR applicants to develop research collaborations with ARS scientists and/or to license ARS technologies. The purpose is to increase the likelihood of success by providing both money and technologies to small U.S. businesses. The relevant language in the SBIR’s “Request for Application” states: “Additional factors that will be considered in the review process include whether an application involves a Cooperative Research and Development Agreement (CRADA) with a USDA laboratory, or a license to a USDA technology, or is a resubmission.”
This webinar will include an overview of the USDA SBIR program and crafting a competitive SBIR proposal. Also an overview of ARS and how to develop a successful research collaboration (CRADA) with an ARS scientist and/or license an ARS technology will be discussed. The webinar will address coordinating the statement of works in an ARS CRADA and a USDA SBIR proposal.
When Subra Suresh was tapped to lead the National Science Foundation (NSF), in 2010, he saw that many of the pathbreaking discoveries developed through the agency’s grants weren’t finding their way to the marketplace, so he sought to foster better links between government and industry.
This, of course, was not an entirely new idea. Over the years, there have been numerous efforts, ranging from the Bayh-Dole Act, of 1980, to numerous initiatives to revamp technology transfer offices within government agencies, but nothing really seemed able to speed new discoveries out of the labs and into the marketplace.
Knowledge of an individual’s skin condition is important for pressure ulcer prevention. Detecting early changes in skin through perfusion, oxygen saturation values, and pressure on tissue and subsequent therapeutic intervention could increase patients’ quality of life drastically. However, most existing sensing options create additional risk of ulcer development due to further pressure on and chafing of the skin. Here, as a first component, we present a flexible, photonic textile-based sensor for the continuous monitoring of the heartbeat and blood flow. Polymer optical fibres (POFs) are melt-spun continuously and characterized optically and mechanically before being embroidered. The resulting sensor shows flexibility when embroidered into a moisture-wicking fabric, and withstands disinfection with hospital-type laundry cycles. Additionally, the new sensor textile shows a lower static coefficient of friction (COF) than conventionally used bedsheets in both dry and sweaty conditions versus a skin model. Finally, we demonstrate the functionality of our sensor by measuring the heartbeat at the forehead in reflection mode and comparing it with commercial finger photoplethysmography for several subjects. Our results will allow the development of flexible, individualized, and fully textile-integrated wearable sensors for sensitive skin conditions and general long-term monitoring of patients with risk for pressure ulcer.
